AMENDMENT NO. 1 TO AMENDED AND RESTATED EQUITY HOLDERS’ AGREEMENTEquity Holders' Agreement • December 22nd, 2015 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Delaware
THIS AMENDMENT NO. 1 TO AMENDED AND RESTATED EQUITY HOLDERS’ AGREEMENT (the “Amendment”), dated effective as of December 17, 2015 (the “Effective Date”), is by and among:
